|
1. Biologie
|
|
|
|
3. Prévention
|
|
|
|
|
3.8 Prévention - Alimentation
|
|
|
|
4. Dépistage, diagnostic et pronostic
|
|
|
|
5. Traitements
|
|
|
Blinatumomab Extends Survival for Patients with Advanced ALL [NCI]
|
|
|
|
|
|
Blinatumomab
is a type of immunotherapy called a bispecific monoclonal antibody.
These drugs bind to two different molecules at the same time. The two
molecules to which blinatumomab binds are a protein (CD19) expressed on
the surface of ALL cells and a protein (CD3) expressed on immune system
cells called T cells.
|
|
|
|
|
|
|
5.12 Immunothérapies
|
|
|
|
5.12.1 Immunothérapies - partenariats
|
|
|
|
5.12.2 Immunothérapies - CAR-T
|
|
|
|
5.2 Pharma
|
|
|
|
5.2.1 Pharma - Partenariats
|
|
|
|
5.3 Traitements - FDA, EMA, NICE...
|
|
|
|
5.9 AACR
|
|
|
|
|
Cancer org bestows award on scientist under investigation [Retraction Watch]
|
|
|
|
|
|
This
month hasn’t been all bad for Carlo Croce. Despite issuing two
corrections and being the subject of a lengthy New York Times article
about how he’s dodged misconduct accusations for years (prompting his
institution to re-open an investigation), Croce is now the recipient of a
prestigious award from the American Association for Cancer Research.
|
|
|
|
|
|
|
6.1 Observation
|
|
|
|
U.S. rates of double-mastectomies for breast cancer vary by state [Reuters]
|
|
|
|
|
|
Between
2010 and 2012, among women ages 20 to 44 with cancer in one breast,
about 15 percent had both breasts removed in the District of Columbia,
compared to about 49 percent in South Dakota. "The variation is very
striking," said senior author Ahmedin Jemal, of the American Cancer
Society in Atlanta.
|
|
|
|
|
|
|
6.10 Politiques
|
|
|
|
6.10.1 Politiques (USA)
|
|
|
|
|
6.11 Patients
|
|
|
|
Young cancer patients may lag peers in social functioning for years [Reuters]
|
|
|
|
|
|
To
see how young cancer patients fared over time, the researchers
recruited 215 cancer patients between the ages of 14 and 39 shortly
after they had been diagnosed at one of five major U.S. hospitals. The
participants answered survey questions within four months after
diagnosis, then again a year later and two years later.
|
|
|
|
|
|
|
6.4 Médico-éco
|
|
|
|
|
6.6 Publications
|
|
|